Exane BNP Paribas analyst Nate Crossett upgraded Omega Healthcare (OHI) to Outperform from Neutral with a $49 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI: